The Interferon-Gamma Paradox in Cancer
Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting paradigm. However, mounting evidence suggests that IFNG may also have important and significant protumor roles to play in the equilibrium and escape...
Saved in:
| Published in: | Journal of interferon & cytokine research Vol. 39; no. 1; p. 30 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01-01-2019
|
| Subjects: | |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting paradigm. However, mounting evidence suggests that IFNG may also have important and significant protumor roles to play in the equilibrium and escape phases through its regulatory effects on immunoevasive functions that promote tumorigenesis. These seemingly contradictory effects of IFNG undoubtedly play profound roles in not only the activation of inflammatory response to cancer but also in the determination of its outcome. In the face of the recent explosion of anticancer immunotherapeutic strategies in the clinic, it is critical that a complete understanding is achieved of the underpinnings of the mechanisms that determine the two faces of IFNG signaling in cancer. Here, the current state of this dichotomy is reviewed. |
|---|---|
| AbstractList | Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting paradigm. However, mounting evidence suggests that IFNG may also have important and significant protumor roles to play in the equilibrium and escape phases through its regulatory effects on immunoevasive functions that promote tumorigenesis. These seemingly contradictory effects of IFNG undoubtedly play profound roles in not only the activation of inflammatory response to cancer but also in the determination of its outcome. In the face of the recent explosion of anticancer immunotherapeutic strategies in the clinic, it is critical that a complete understanding is achieved of the underpinnings of the mechanisms that determine the two faces of IFNG signaling in cancer. Here, the current state of this dichotomy is reviewed. |
| Author | Zaidi, M Raza |
| Author_xml | – sequence: 1 givenname: M Raza surname: Zaidi fullname: Zaidi, M Raza organization: Fels Institute for Cancer Research & Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30388040$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1zjtPwzAUQGELgegDRlaUiS3p9Su-HlEEpVIlOpS5urFvRCriVE6R4N8zANPZPp2FuExjYiHuJFQS0K-Ofa4USKwA0F2IubTWlc7UdiYW03QEgBqVvxYzDRoRDMzFw_6di006c-44j6lc0zBQsaNMcfwq-lQ0lALnG3HV0cfEt39dirfnp33zUm5f15vmcVsGI-257Nhp5Z2JzGA6CdqSJlDWekIvfUSFdavAOam0kyawa70O5JCipkBaLcX9r3v6bAeOh1PuB8rfh_9h9QPlUD_G |
| CitedBy_id | crossref_primary_10_3389_fimmu_2023_1200282 crossref_primary_10_3390_cells10061356 crossref_primary_10_3389_fonc_2023_1080519 crossref_primary_10_3389_fonc_2022_955979 crossref_primary_10_1038_s41416_021_01425_7 crossref_primary_10_1371_journal_pone_0286122 crossref_primary_10_1016_j_devcel_2022_03_001 crossref_primary_10_1038_s41388_022_02376_w crossref_primary_10_1080_15569543_2020_1818107 crossref_primary_10_3390_vaccines9070786 crossref_primary_10_1016_j_biomaterials_2024_122688 crossref_primary_10_3390_ijms25042153 crossref_primary_10_3390_cancers12092620 crossref_primary_10_1016_j_prp_2022_154039 crossref_primary_10_1186_s12885_022_09963_w crossref_primary_10_18632_oncotarget_27977 crossref_primary_10_3390_cancers14194957 crossref_primary_10_1016_j_cyto_2022_156051 crossref_primary_10_1093_intimm_dxab099 crossref_primary_10_1002_advs_202404131 crossref_primary_10_3892_or_2021_8225 crossref_primary_10_3390_ijerph18179345 crossref_primary_10_3390_curroncol29050247 crossref_primary_10_1016_j_biochi_2019_11_018 crossref_primary_10_3390_cancers13040734 crossref_primary_10_1172_JCI138760 crossref_primary_10_3390_cancers13040821 crossref_primary_10_3390_ijms21228485 crossref_primary_10_3390_cancers14143513 crossref_primary_10_3390_molecules26133888 crossref_primary_10_1038_s41388_022_02561_x crossref_primary_10_1038_s41598_019_55683_w crossref_primary_10_1111_ejh_13921 crossref_primary_10_1002_ctm2_582 crossref_primary_10_3390_ijms25116103 crossref_primary_10_3390_biomedicines11010008 crossref_primary_10_3390_cancers13030373 crossref_primary_10_1016_j_biosx_2022_100122 crossref_primary_10_1016_j_cyto_2021_155637 crossref_primary_10_1016_j_cyto_2022_155836 crossref_primary_10_1186_s40364_020_00228_x crossref_primary_10_1177_15347354221096668 crossref_primary_10_3390_v15071454 crossref_primary_10_1080_2162402X_2022_2109861 crossref_primary_10_1002_cti2_1519 crossref_primary_10_3389_fmolb_2024_1334876 crossref_primary_10_1016_j_cyto_2023_156376 crossref_primary_10_1016_j_isci_2023_106666 crossref_primary_10_1016_j_jtauto_2021_100098 crossref_primary_10_1016_j_ygyno_2023_06_581 crossref_primary_10_1016_j_addr_2022_114112 crossref_primary_10_3892_mco_2024_2747 crossref_primary_10_1038_s41419_020_2636_4 crossref_primary_10_1007_s00280_024_04691_3 crossref_primary_10_1016_j_xcrm_2021_100353 crossref_primary_10_1186_s12885_020_06835_z crossref_primary_10_1002_adfm_202003479 crossref_primary_10_3389_fimmu_2023_1267866 crossref_primary_10_1016_j_isci_2022_104193 crossref_primary_10_1016_j_cyto_2019_154743 crossref_primary_10_3389_fcell_2020_00402 crossref_primary_10_1111_pcmr_13036 crossref_primary_10_1016_j_lfs_2023_121997 crossref_primary_10_1159_000530184 crossref_primary_10_3390_ijms241813937 crossref_primary_10_3390_antiox11122394 crossref_primary_10_4236_ojmm_2022_124011 crossref_primary_10_3389_fonc_2021_749003 crossref_primary_10_1111_1759_7714_13978 crossref_primary_10_1248_yakushi_22_00150 crossref_primary_10_4049_jimmunol_2300475 crossref_primary_10_1007_s12015_023_10639_6 crossref_primary_10_3390_cancers14041028 crossref_primary_10_1093_biolre_ioab186 crossref_primary_10_3389_fonc_2023_1285117 crossref_primary_10_1007_s00018_020_03696_4 crossref_primary_10_1002_iid3_867 crossref_primary_10_3390_ijms22041964 crossref_primary_10_3390_vaccines9111247 crossref_primary_10_1016_j_biocel_2021_106093 crossref_primary_10_1136_jitc_2022_005560 crossref_primary_10_1002_adma_202103258 crossref_primary_10_1007_s00262_020_02810_6 crossref_primary_10_1016_j_intimp_2023_110688 crossref_primary_10_1016_j_ajpath_2024_03_004 crossref_primary_10_3389_fimmu_2023_1237623 crossref_primary_10_1155_2022_5492602 crossref_primary_10_1161_CIRCULATIONAHA_122_062551 crossref_primary_10_3389_fimmu_2023_1335207 crossref_primary_10_1016_j_cytogfr_2020_10_007 crossref_primary_10_3390_v11060514 crossref_primary_10_3389_fimmu_2023_1190333 crossref_primary_10_1038_s41591_024_02805_1 crossref_primary_10_1038_s41388_023_02874_5 crossref_primary_10_3389_pore_2021_622733 crossref_primary_10_3390_cancers12123694 crossref_primary_10_1016_j_bbrep_2021_101053 crossref_primary_10_1016_j_intimp_2022_109569 crossref_primary_10_1080_15368378_2021_2006689 crossref_primary_10_3390_ijms21197139 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1089/jir.2018.0087 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1557-7465 |
| ExternalDocumentID | 30388040 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA193711 |
| GroupedDBID | --- .GJ 0R~ 1-M 29K 34G 39C 3V. 4.4 53G 5GY 5RE 7X7 88A 88E 88I 8C1 8FE 8FH 8FI 8FJ ABBKN ABJNI ABOCM ABUWG ACGFS ACGOD ACPRK ADBBV ADFRT AENEX AFFNX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BNQNF BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF D-I DU5 DWQXO EBS ECM EIF EJD F5P FYUFA GNUQQ HCIFZ HMCUK IAO IER IHR IM4 ITC L7B LK8 M0L M1P M2P M7P MV1 NPM NQHIM O9- P2P PQQKQ PROAC PSQYO RIG RML UE5 UKHRP ZGI |
| ID | FETCH-LOGICAL-c415t-fe732974dee04f1035a3a02559a8919d8286b2077123714ce7b93ca78ad3aca32 |
| IngestDate | Sat Sep 28 08:29:49 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | cytokine signaling immunoevasion cancer immunosurveillance interferon-gamma immunoediting |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c415t-fe732974dee04f1035a3a02559a8919d8286b2077123714ce7b93ca78ad3aca32 |
| OpenAccessLink | https://europepmc.org/articles/pmc6350411?pdf=render |
| PMID | 30388040 |
| ParticipantIDs | pubmed_primary_30388040 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-00 |
| PublicationDateYYYYMMDD | 2019-01-01 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of interferon & cytokine research |
| PublicationTitleAlternate | J Interferon Cytokine Res |
| PublicationYear | 2019 |
| SSID | ssj0006829 |
| Score | 2.5813127 |
| SecondaryResourceType | review_article |
| Snippet | Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 30 |
| SubjectTerms | Animals Humans Interferon-gamma - immunology Neoplasms - immunology Signal Transduction - immunology |
| Title | The Interferon-Gamma Paradox in Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30388040 |
| Volume | 39 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NS8MwFA9OcewiOr-_6EG8SLFt0qU9ypx6mQedIF7Ga5tAlbVjTnD-9b4kbd0mQz14CSUhJX2_5OW917xfCDmJcItyJXonEZWxzaR07UAEvi04lagOKVDQoYt7fvsYXHZYp7xLHr3-qu5fkcY6xFplzv4B7eqlWIHPiDmWiDqWv8Zdh_mkGOWZfQ2DAaCdOIIkf9cpfgrm0QKbNK066ikRT8b5izJDC0qgKnT8BGmijwF0z-7gA6ZDBypbqQodiELd-dzmzNzWUOpDQy40g7tRbuYHyjed6wSKsvQ5VeyqrjqZanbQKVkPB1rYVDPPMOfn1jkK7LKpRmpo0Cibt92ttttW4IUFeSqO5HxmHA1SL_vOuQ3afOitk7VCxtaFAWyDLImsSVbNTaCTJql3izMOm-QUEbTmEbQKBK00swyCW-ThqtNr39jFbRZ2jEbS2JY4_T303hIhHCZdh_q4DrRHB0HohonK5488h3O0JbjLYsGjkMbAA0goxEC9bbKc5ZnYJVbksMSTvheDygz2fWCu57AYWCQTH1qtPbJjvrU_NJQl_VIK-wtbDkjja4ockhWJ60Eckdpr8nasBf4JMYwl8A |
| link.rule.ids | 782 |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Interferon-Gamma+Paradox+in+Cancer&rft.jtitle=Journal+of+interferon+%26+cytokine+research&rft.au=Zaidi%2C+M+Raza&rft.date=2019-01-01&rft.eissn=1557-7465&rft.volume=39&rft.issue=1&rft.spage=30&rft_id=info:doi/10.1089%2Fjir.2018.0087&rft_id=info%3Apmid%2F30388040&rft_id=info%3Apmid%2F30388040&rft.externalDocID=30388040 |